As of April 2026 Regeneron Pharmaceuticals has a market cap of NZ$142.18 Billion. This makes Regeneron Pharmaceuticals the world's 275th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 31st, 2026 the market cap of Regeneron Pharmaceuticals was reported to be: